The effect of sleep disturbance on quality of life in women with ovarian cancer

Sandadi, Samith; Frasure, Heidi E.; Broderick, Meredith; Waggoner, Steven; Miller, Jacqualin A.; Gruenigen, Vivian E. von

doi:10.1016/j.ygyno.2011.07.028

Cited by 64 publications

(75 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The samples represented a variety of clinical disorders, including cancer [35,36,50,72], schizophrenia, and chronic fatigue syndrome [63,68], as well as healthy participants of varying ages [40,41,49,51], sexes [46e80], and races and ethnicities [49,78].…”

Section: Search Resultsmentioning

confidence: 99%

The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis

Mollayeva

Thurairajah

Burton

et al. 2016

Sleep Medicine Reviews

1,254

854

View full text Add to dashboard Cite

Section: Search Resultsmentioning

confidence: 99%

The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis

Mollayeva

Thurairajah

Burton

et al. 2016

Sleep Medicine Reviews

1,254

854

View full text Add to dashboard Cite

“…These symptoms often exist before the start of chemotherapy treatment [3–5], and significantly impact patients’ quality of life (QoL) [6–9]. However, less is known about the trajectory of these symptoms over time, particularly after the end of chemotherapy.…”

Section: Introductionmentioning

confidence: 99%

Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study

Ancoli‐Israel

Liu

Rissling

et al. 2014

Support Care Cancer

191

156

View full text Add to dashboard Cite

Purpose Sleep disturbance, fatigue and depression are common complaints in patients with cancer, and often contribute to worse quality of life (QoL). Circadian activity rhythms (CARs) are often disrupted in cancer patients. These symptoms worsen during treatment, but less is known about their long-term trajectory. Methods Sixty-eight women with stage I-III breast cancer (BC) scheduled to receive ≥4 cycles of chemotherapy, and age-, ethnicity- and education-matched normal, cancer-free controls (NC) participated. Sleep was measured with actigraphy (nocturnal total sleep time [nocturnal TST] and daytime total nap time [NAPTIME]) and with the Pittsburgh Sleep Quality Index (PSQI); fatigue with the Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF); depression with the Center of Epidemiological Studies-Depression (CES-D). CARs were derived from actigraphy. Several measures of QoL were administered. Data were collected at three time points: before (Baseline), end of cycle 4 (Cycle-4), and one year post-chemotherapy (1-Year). Results Compared to NC, BC had longer NAPTIME, worse sleep quality, more fatigue, more depressive symptoms, more disrupted CARs and worse QoL at Baseline (all p’s<0.05). At Cycle-4, BC showed worse sleep, increased fatigue, more depressive symptoms, and more disrupted CARs compared to their own Baseline levels and to NC (all p’s<0.05). By 1-year, BC’s fatigue, depressive symptoms and QoL returned to Baseline levels but were still worse than those of NC, while NAPTIME and CARs did not differ from NC’s. Conclusion Additional research is needed to determine if beginning treatment of these symptoms before the start of chemotherapy will minimize symptom severity over time.

show abstract

“…Particularly fatigue, insomnia, and inactivity can affect up to 70% of cancer populations (Jim et al 2011). These symptoms have a negative impact on the quality of life in patients with cancer resulting in reduced ability to take part in activities of daily living (Gupta et al 2007;Munir et al 2009;Dodd et al 2010;Sandadi et al 2011). Fatigue may also lead to poor compliance and withdrawal from chemotherapy (Morrow et al 2002;Hofman et al 2007), and eventually it may influence the survival rate.…”

Section: Introductionmentioning

confidence: 99%

Circadian rhythms measured by actigraphy during oncological treatments: a systematic review

Huang

Madsen

Gögenür

2015

Biological Rhythm Research

View full text Add to dashboard Cite

During oncological treatment patients often suffer from fatigue, insomnia, and daytime inactivity. This cluster of symptoms and overall survival are linked with circadian rhythm disruptions in rest-activity, which can be objectively characterized using actigraphy. We systematically reviewed the body of literature using actigraphy to characterize the circadian rhythm disruption in patients during oncological treatments and studies that introduced interventions to deal with this disruption. Thirteen observational and two interventional studies were included in this review. These mainly described patients with breast cancer undergoing chemotherapy, and the disruptions were persistent among these patients, and the disruptions peaked at the start of chemotherapy cycles and decreased during the periods in between. Light and behavioral therapy showed some alleviating effects in patients with breast cancer. We also found that circadian rhythm disruptions were prevalent in patients during other cancer therapies. Effective cancer therapy controls cancer growth and improves circadian organization. Cancer therapy itself, however, also contributes to cancer associated circadian dys-synchrony. Interrupting this vicious cycle represents an important opportunity for diminishing cancer patients' suffering and improving or even prolonging their useful and enjoyable lives.

show abstract

The effect of sleep disturbance on quality of life in women with ovarian cancer

Cited by 64 publications

References 31 publications

The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis

The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis

Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study

Circadian rhythms measured by actigraphy during oncological treatments: a systematic review

Contact Info

Product

Resources

About